Relaxo Footwears Zukünftiges Wachstum
Future Kriterienprüfungen 4/6
Relaxo Footwears wird ein jährliches Gewinn- und Umsatzwachstum von 23.3% bzw. 11% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 23.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 12.8% betragen.
Wichtige Informationen
23.3%
Wachstumsrate der Gewinne
23.2%
EPS-Wachstumsrate
Luxury Gewinnwachstum | 25.8% |
Wachstumsrate der Einnahmen | 11.0% |
Zukünftige Eigenkapitalrendite | 12.8% |
Analystenabdeckung | Good |
Zuletzt aktualisiert | 16 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
The Returns On Capital At Relaxo Footwears (NSE:RELAXO) Don't Inspire Confidence
Oct 18Pinning Down Relaxo Footwears Limited's (NSE:RELAXO) P/S Is Difficult Right Now
Sep 19We Think Shareholders May Want To Consider A Review Of Relaxo Footwears Limited's (NSE:RELAXO) CEO Compensation Package
Aug 23Relaxo Footwears (NSE:RELAXO) Will Pay A Larger Dividend Than Last Year At ₹3.00
Aug 03Relaxo Footwears (NSE:RELAXO) Seems To Use Debt Quite Sensibly
Jun 01Relaxo Footwears (NSE:RELAXO) Will Want To Turn Around Its Return Trends
Apr 26There's Reason For Concern Over Relaxo Footwears Limited's (NSE:RELAXO) Price
Mar 14Relaxo Footwears (NSE:RELAXO) Might Be Having Difficulty Using Its Capital Effectively
Dec 01Is Relaxo Footwears (NSE:RELAXO) A Risky Investment?
Nov 09Relaxo Footwears (NSE:RELAXO) Is Paying Out A Dividend Of ₹2.50
Aug 10Relaxo Footwears (NSE:RELAXO) Will Pay A Dividend Of ₹2.50
Jul 27Relaxo Footwears (NSE:RELAXO) Will Want To Turn Around Its Return Trends
Jun 29These 4 Measures Indicate That Relaxo Footwears (NSE:RELAXO) Is Using Debt Reasonably Well
Mar 20Some Investors May Be Worried About Relaxo Footwears' (NSE:RELAXO) Returns On Capital
Dec 27Is Relaxo Footwears (NSE:RELAXO) Using Too Much Debt?
Nov 30Relaxo Footwears (NSE:RELAXO) Is Reinvesting At Lower Rates Of Return
Sep 02Relaxo Footwears (NSE:RELAXO) Will Pay A Dividend Of ₹2.50
Aug 06Relaxo Footwears' (NSE:RELAXO) Dividend Will Be ₹2.50
Jul 23Does Relaxo Footwears (NSE:RELAXO) Have A Healthy Balance Sheet?
Jul 12Here's Why I Think Relaxo Footwears (NSE:RELAXO) Might Deserve Your Attention Today
May 12Here's Why Relaxo Footwears (NSE:RELAXO) Can Manage Its Debt Responsibly
Mar 06Do Relaxo Footwears's (NSE:RELAXO) Earnings Warrant Your Attention?
Jan 30Relaxo Footwears' (NSE:RELAXO) Returns On Capital Not Reflecting Well On The Business
Dec 16Here's Why I Think Relaxo Footwears (NSE:RELAXO) Might Deserve Your Attention Today
Oct 14Relaxo Footwears (NSE:RELAXO) Might Be Having Difficulty Using Its Capital Effectively
Sep 06We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Relaxo Footwears Limited's (NSE:RELAXO) CEO For Now
Aug 19Here's Why We Think Relaxo Footwears (NSE:RELAXO) Is Well Worth Watching
Jul 08The Returns On Capital At Relaxo Footwears (NSE:RELAXO) Don't Inspire Confidence
May 11Is Relaxo Footwears (NSE:RELAXO) Using Too Much Debt?
Mar 08Is Relaxo Footwears Limited's (NSE:RELAXO) Latest Stock Performance A Reflection Of Its Financial Health?
Feb 18Should You Be Adding Relaxo Footwears (NSE:RELAXO) To Your Watchlist Today?
Feb 03Introducing Relaxo Footwears (NSE:RELAXO), The Stock That Zoomed 266% In The Last Five Years
Jan 19What Do The Returns On Capital At Relaxo Footwears (NSE:RELAXO) Tell Us?
Jan 06Trade Alert: The Whole-Time Director Of Relaxo Footwears Limited (NSE:RELAXO), Deval Ganguly, Has Sold Some Shares Recently
Dec 24A Look At The Intrinsic Value Of Relaxo Footwears Limited (NSE:RELAXO)
Dec 20Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
3/31/2027 | 37,827 | 3,207 | 2,861 | 4,370 | 10 |
3/31/2026 | 34,032 | 2,652 | 2,062 | 3,739 | 12 |
3/31/2025 | 30,338 | 2,053 | 3,056 | 4,458 | 12 |
9/30/2024 | 28,879 | 1,811 | -35 | 2,443 | N/A |
6/30/2024 | 29,234 | 1,885 | N/A | N/A | N/A |
3/31/2024 | 29,145 | 2,005 | -143 | 2,351 | N/A |
12/31/2023 | 29,318 | 2,024 | N/A | N/A | N/A |
9/30/2023 | 29,001 | 1,939 | 2,290 | 3,758 | N/A |
6/30/2023 | 28,544 | 1,721 | N/A | N/A | N/A |
3/31/2023 | 27,834 | 1,545 | 2,149 | 4,001 | N/A |
12/31/2022 | 27,160 | 1,541 | N/A | N/A | N/A |
9/30/2022 | 27,785 | 1,941 | 374 | 2,149 | N/A |
6/30/2022 | 28,233 | 2,404 | N/A | N/A | N/A |
3/31/2022 | 26,533 | 2,327 | -835 | 560 | N/A |
12/31/2021 | 27,028 | 2,719 | N/A | N/A | N/A |
9/30/2021 | 26,313 | 2,919 | 710 | 2,293 | N/A |
6/30/2021 | 24,927 | 2,983 | N/A | N/A | N/A |
3/31/2021 | 23,592 | 2,916 | 3,898 | 5,131 | N/A |
12/31/2020 | 21,521 | 2,412 | N/A | N/A | N/A |
9/30/2020 | 20,799 | 2,053 | 3,737 | 4,489 | N/A |
6/30/2020 | 21,258 | 2,007 | N/A | N/A | N/A |
3/31/2020 | 24,105 | 2,263 | 2,028 | 3,189 | N/A |
12/31/2019 | 25,056 | 2,289 | N/A | N/A | N/A |
9/30/2019 | 24,570 | 2,103 | 462 | 1,669 | N/A |
6/30/2019 | 23,784 | 1,792 | N/A | N/A | N/A |
3/31/2019 | 22,921 | 1,754 | 311 | 1,235 | N/A |
12/31/2018 | 22,226 | 1,745 | N/A | N/A | N/A |
9/30/2018 | 21,258 | 1,771 | N/A | N/A | N/A |
6/30/2018 | 20,404 | 1,697 | N/A | N/A | N/A |
3/31/2018 | 19,411 | 1,611 | N/A | 1,543 | N/A |
12/31/2017 | 19,787 | 1,423 | N/A | N/A | N/A |
9/30/2017 | 18,874 | 1,285 | N/A | N/A | N/A |
6/30/2017 | 18,176 | 1,233 | N/A | N/A | N/A |
3/31/2017 | 16,312 | 1,200 | N/A | 1,802 | N/A |
12/31/2016 | 17,268 | 1,215 | N/A | N/A | N/A |
9/30/2016 | 17,247 | 1,208 | N/A | N/A | N/A |
6/30/2016 | 16,930 | 1,205 | N/A | N/A | N/A |
3/31/2016 | 17,118 | 1,203 | N/A | 1,594 | N/A |
12/31/2015 | 16,679 | 1,301 | N/A | N/A | N/A |
9/30/2015 | 16,128 | 1,256 | N/A | N/A | N/A |
6/30/2015 | 15,604 | 1,159 | N/A | N/A | N/A |
3/31/2015 | 14,808 | 1,030 | N/A | 1,075 | N/A |
12/31/2014 | 14,115 | 822 | N/A | N/A | N/A |
9/30/2014 | 13,401 | 729 | N/A | N/A | N/A |
6/30/2014 | 12,716 | 672 | N/A | N/A | N/A |
3/31/2014 | 12,123 | 656 | N/A | 1,249 | N/A |
12/31/2013 | 11,312 | 573 | N/A | N/A | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: RELAXODas prognostizierte Gewinnwachstum (23.3% pro Jahr) liegt über der Sparquote (6.7%).
Ertrag vs. Markt: RELAXODie Erträge des Unternehmens (23.3% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (18% pro Jahr).
Hohe Wachstumserträge: RELAXOEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: RELAXODie Einnahmen des Unternehmens (11% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Indian (10.5% pro Jahr).
Hohe Wachstumseinnahmen: RELAXODie Einnahmen des Unternehmens (11% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: RELAXODie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (12.8%).